As leaders of organizations in the field of cancer research, we are writing to share our concerns regarding the indirect downstream impacts of the Patented Medicine Prices Review Board (PMPRB) regulation changes on the health and quality of Canada’s biomedical research ecosystem.
Read the full submission:
CHRF_PMPRB GMEP Submission_Final
.pdf
Download PDF • 464KB